EX-10.1 2 dex101.htm TRIPARTITE COOPERATION AGREEMENTTripartite Cooperation Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionCERTAIN INFORMATION IN THIS EXHIBIT IS SUBJECT TO A REQUEST FOR CONFIDENTIAL TREATMENT. IN ACCORDANCE WITH RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, SUCH INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. THE LOCATION OF SUCH OMITTED INFORMATION HAS BEEN INDICATED WITH ASTERISKS (*****).
TRIPARTITE COOPERATION AGREEMENT By and Between NOVARTIS PHARMA AG GENENTECH, INC. AND TANOX, INC. Dated as of February 25, 2004Tripartite Cooperation Agreement • May 10th, 2004 • Tanox Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2004 Company Industry Jurisdiction